Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| epithelial cell | 6 studies | 29% ± 10% | |
| goblet cell | 4 studies | 20% ± 1% | |
| classical monocyte | 3 studies | 26% ± 8% | |
| ciliated cell | 3 studies | 21% ± 5% | |
| astrocyte | 3 studies | 24% ± 3% | |
| intestinal crypt stem cell | 3 studies | 18% ± 3% | |
| basal cell | 3 studies | 25% ± 4% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| peripheral blood | 3 studies | 21% ± 6% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| prostate | 100% | 6510.14 | 245 / 245 | 100% | 150.06 | 502 / 502 |
| stomach | 100% | 5962.73 | 359 / 359 | 100% | 120.97 | 286 / 286 |
| esophagus | 100% | 6677.87 | 1444 / 1445 | 100% | 105.30 | 183 / 183 |
| lung | 100% | 5809.37 | 577 / 578 | 100% | 116.28 | 1155 / 1155 |
| breast | 100% | 6357.27 | 459 / 459 | 100% | 169.26 | 1116 / 1118 |
| intestine | 100% | 5609.52 | 966 / 966 | 100% | 138.70 | 526 / 527 |
| skin | 100% | 9708.02 | 1809 / 1809 | 100% | 118.78 | 471 / 472 |
| ovary | 100% | 4392.14 | 180 / 180 | 100% | 102.02 | 429 / 430 |
| pancreas | 100% | 5279.96 | 327 / 328 | 100% | 90.98 | 178 / 178 |
| bladder | 100% | 6125.05 | 21 / 21 | 100% | 148.08 | 502 / 504 |
| uterus | 100% | 4742.52 | 170 / 170 | 100% | 120.30 | 457 / 459 |
| thymus | 100% | 4319.75 | 652 / 653 | 100% | 87.79 | 602 / 605 |
| liver | 100% | 3223.55 | 226 / 226 | 98% | 66.87 | 397 / 406 |
| adrenal gland | 100% | 6166.83 | 258 / 258 | 95% | 60.00 | 218 / 230 |
| kidney | 99% | 2745.30 | 88 / 89 | 91% | 47.15 | 820 / 901 |
| brain | 82% | 2254.29 | 2162 / 2642 | 95% | 37.56 | 669 / 705 |
| adipose | 100% | 6014.15 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 135.01 | 29 / 29 |
| spleen | 100% | 7060.69 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 121.90 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 51.99 | 1 / 1 |
| blood vessel | 100% | 4585.07 | 1334 / 1335 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 99% | 69.48 | 79 / 80 |
| peripheral blood | 97% | 4579.24 | 898 / 929 | 0% | 0 | 0 / 0 |
| heart | 93% | 2201.20 | 804 / 861 | 0% | 0 | 0 / 0 |
| muscle | 84% | 1609.07 | 673 / 803 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0030071 | Biological process | regulation of mitotic metaphase/anaphase transition |
| GO_0045582 | Biological process | positive regulation of T cell differentiation |
| GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
| GO_2000045 | Biological process | regulation of G1/S transition of mitotic cell cycle |
| GO_0045663 | Biological process | positive regulation of myoblast differentiation |
| GO_0006338 | Biological process | chromatin remodeling |
| GO_0070316 | Biological process | regulation of G0 to G1 transition |
| GO_0045597 | Biological process | positive regulation of cell differentiation |
| GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
| GO_2000819 | Biological process | regulation of nucleotide-excision repair |
| GO_0006337 | Biological process | nucleosome disassembly |
| GO_2000781 | Biological process | positive regulation of double-strand break repair |
| GO_0000776 | Cellular component | kinetochore |
| GO_0032991 | Cellular component | protein-containing complex |
| GO_0016514 | Cellular component | SWI/SNF complex |
| GO_0005654 | Cellular component | nucleoplasm |
| GO_0016363 | Cellular component | nuclear matrix |
| GO_0016586 | Cellular component | RSC-type complex |
| GO_0035060 | Cellular component | brahma complex |
| GO_0000785 | Cellular component | chromatin |
| GO_0140092 | Cellular component | bBAF complex |
| GO_0005634 | Cellular component | nucleus |
| GO_0031492 | Molecular function | nucleosomal DNA binding |
| GO_0003712 | Molecular function | transcription coregulator activity |
| GO_0003713 | Molecular function | transcription coactivator activity |
| GO_0005515 | Molecular function | protein binding |
| Gene name | SMARCD2 |
| Protein name | SMARCD2 protein SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily D member 2 (60 kDa BRG-1/Brm-associated factor subunit B) (BRG1-associated factor 60B) (BAF60B) SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 2 |
| Synonyms | PRO2451 BAF60B |
| Description | FUNCTION: Involved in transcriptional activation and repression of select genes by chromatin remodeling (alteration of DNA-nucleosome topology). Component of SWI/SNF chromatin remodeling complexes that carry out key enzymatic activities, changing chromatin structure by altering DNA-histone contacts within a nucleosome in an ATP-dependent manner . Critical regulator of myeloid differentiation, controlling granulocytopoiesis and the expression of genes involved in neutrophil granule formation . . |
| Accessions | A0A8V8TLF4 A0A8V8TN45 ENST00000580054.1 Q92925 ENST00000225742.13 J3KT18 ENST00000584400.5 ENST00000698016.1 B9EGA3 ENST00000448276.7 [Q92925-1] J3QQL7 ENST00000577990.1 A0A8V8TLC9 J3QWB6 J3KMX2 ENST00000698027.1 J3QS33 ENST00000450364.3 ENST00000323347.14 [Q92925-3] ENST00000698021.1 A0A8V8TLV3 ENST00000698022.1 |
